News & Trends - Pharmaceuticals
Organon ANZ unveils dedicated innovation team

Pharma News: In a strategic move, Organon ANZ has reshaped its organisational structure to pave the way for greater employee development and business growth. The company has introduced a visionary Strategy and Business Excellence team, marking the debut of their dedicated innovation function. This dynamic initiative seeks not only to strengthen the company’s position in the healthcare industry but also to empower women’s healthcare needs while building a foundation for a better society.
Nirelle Tolstoshev, Managing Director of Organon ANZ, stated “We believe that being a leading partner in women’s healthcare not only supports the well-being of women but also lays the groundwork for a stronger and healthier society.”
As Organon ANZ celebrated its second anniversary in June, the time was ripe for a strategic review, a period that marked the commencement of their next phase of growth.
Ms Tolstoshev further explained, “We recognised the importance of re-evaluating our integration across the entire business to ensure that we possess the future-ready skills and structure necessary to cater to the evolving needs of healthcare providers and patients.”
The aim was clear: to remain agile and adaptable, staying ahead in a rapidly changing market and regulatory landscape.
The crown jewel of this transformation is the newly established Strategy & Business Excellence team. This group will drive the company forward by fostering fast-moving innovation and streamlined decision-making processes. Headed by Meaghan Clarke, this team is entrusted with critical responsibilities, including organisational strategy, business development, pipeline planning, data & insights, and customer experience.
Ms Clarke brings a wealth of expertise and a sharp business acumen from her extensive experience in the pharmaceutical sector across multiple commercial and therapeutic areas. Her leadership promises to be a guiding force in steering Organon ANZ towards new horizons of success.
“At the core of Organon’s inception lies a commitment to listening – to our patients, customers, and our workforce. We value feedback and have learned through employee engagement surveys and other mechanisms that our business must adapt continuously to anticipate our customers’ needs,” expressed Ms Tolstoshev with unwavering determination.
Organon ANZ’s unwavering dedication to its employees and customers has undoubtedly contributed to its remarkable growth. Now, with the formation of the Strategy & Business Excellence team, the company is poised to take innovation to new heights, ensuring that its culture remains vibrant and that it attracts the best talent to nurture its in-house expertise.
Reimagining healthcare across the entire patient journey: Health Industry HubTM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change in healthcare.
The content on Health Industry Hub is copyright protected and can only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.
Digital & Innovation

Liverpool Hospital partners with Microsoft in cardiology care
Digital & Innovation: Liverpool Hospital and tech giant Microsoft have joined forces in a collaboration aimed at enhancing the way […]
MoreNews & Trends - MedTech & Diagnostics

Sydney cancer centre welcomes new medical technology ahead of grand opening
MedTech & Diagnostics News: A $52 million integrated cancer treatment facility in Campbelltown, located in south-western Sydney, is swiftly advancing […]
MoreNews & Trends - Pharmaceuticals

Largest pharmacy retailer ASX debut via wholesaler takeover sparks industry concerns
Pharma News: Australia’s largest pharmacy retailer is gearing up for a significant move as it eyes a listing on the […]
MoreNews & Trends - Pharmaceuticals

Eli Lilly’s rheumatoid arthritis medicine to slow progression of type 1 diabetes, say Aussie researchers
Pharma News: Australian researchers have shown that a commonly prescribed rheumatoid arthritis medicine can stop the progression of type 1 […]
More